Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:504476OMIM:614575G11.2
Who is this for?
Show terms as
3Active trials3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) is a rare, slowly progressive neurological disorder that affects the cerebellum, peripheral nerves, and vestibular system. It is caused by biallelic intronic pentanucleotide repeat expansions (AAGGG) in the RFC1 gene. CANVAS was initially considered a sporadic condition, but it is now recognized as an autosomal recessive genetic disorder. The disease typically presents in adulthood, usually between the ages of 40 and 70, and is characterized by the triad of cerebellar ataxia (impaired coordination and balance due to cerebellar dysfunction), sensory neuropathy (damage to peripheral nerves affecting sensation), and bilateral vestibular areflexia (loss of function in both inner ear balance organs). Patients commonly experience progressive unsteadiness, oscillopsia (visual disturbance where objects appear to bounce or oscillate), impaired proprioception, and a chronic dry cough that may precede neurological symptoms by years. The combination of cerebellar, vestibular, and sensory nerve dysfunction leads to significant balance impairment that is often more severe than would be expected from any single component alone. Additional features may include autonomic dysfunction and downbeat nystagmus. Nerve conduction studies typically reveal a sensory neuronopathy (ganglionopathy), and vestibular testing confirms absent or markedly reduced vestibular responses bilaterally. Brain MRI may show cerebellar atrophy, particularly of the vermis. There is currently no disease-modifying treatment for CANVAS. Management is supportive and includes physical therapy and vestibular rehabilitation to optimize balance and mobility, occupational therapy, and assistive devices as needed. The identification of RFC1 repeat expansions as the genetic cause has significantly improved diagnostic accuracy and genetic counseling for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Demyelinating peripheral neuropathyHP:0007108Vestibular areflexiaHP:0008568
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

3 events
Mar 2025Evaluation of Urinary Dysfunction in CANVAS Patients

Centre Hospitalier Universitaire de Nice — NA

TrialRECRUITING
Oct 2024Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS

Catholic University of the Sacred Heart — NA

TrialRECRUITING
Dec 2021RFC1 Natural History Study

Prof. Dr. Matthis Synofzik

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome.

3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

3 recruitingView all trials with filters →
N/A2 trials
Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS
N/A
Actively Recruiting
PI: Gabriella Silvestri (Catholic University of the Sacred Heart) · Sites: Bologna; Roma · Age: 1880 yrs
Evaluation of Urinary Dysfunction in CANVAS Patients
N/A
Actively Recruiting
· Sites: Nice, Alpes Maritimes; Montpellier, Hérault +1 more · Age: 1899 yrs
Other1 trial
RFC1 Natural History Study
Actively Recruiting
PI: Matthis Synofzik, Prof. Dr. (University Hospital Tübingen) · Sites: Melbourne, Victoria; São Paulo, State of São Paulo +8 more · Age: 1899 yrs

Specialists

3 foundView all specialists →
MD
Matthis Synofzik, Prof. Dr.
Specialist
PI on 2 active trials
AM
Astrid Crespo, MD,PhD
Specialist
PI on 1 active trial
GS
Gabriella Silvestri
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndromeForum →

No community posts yet. Be the first to share your experience with Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome.

Start the conversation →

Latest news about Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

Disease timeline:

New recruiting trial: Evaluation of Urinary Dysfunction in CANVAS Patients

A new clinical trial is recruiting patients for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

New recruiting trial: Pathogenic Insights and Search for Biomarkers in RFC1-ataxia/CANVAS

A new clinical trial is recruiting patients for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

New recruiting trial: RFC1 Natural History Study

A new clinical trial is recruiting patients for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome

What is Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome?

Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS) is a rare, slowly progressive neurological disorder that affects the cerebellum, peripheral nerves, and vestibular system. It is caused by biallelic intronic pentanucleotide repeat expansions (AAGGG) in the RFC1 gene. CANVAS was initially considered a sporadic condition, but it is now recognized as an autosomal recessive genetic disorder. The disease typically presents in adulthood, usually between the ages of 40 and 70, and is characterized by the triad of cerebellar ataxia (impaired coordination and balanc

How is Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome inherited?

Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome typically begin?

Typical onset of Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome?

Yes — 3 recruiting clinical trials are currently listed for Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome?

3 specialists and care centers treating Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.